Guo Q, Chang S, Diekman L, Xiao G, Kulmacz R J
Department of Internal Medicine, University of Texas Health Science Center at Houston, 77030, USA.
Arch Biochem Biophys. 1997 Aug 1;344(1):150-8. doi: 10.1006/abbi.1997.0192.
Prostaglandin H synthase (PGHS) catalyzes a key step in the biosynthesis of a variety of bioactive lipid mediators. The two known isoforms (PGHS-1 and -2) share about 60% amino acid identity, but exhibit distinct interactions with substrates, activators, and inhibitors. Ovine PGHS-1 has previously been shown to have a distinctive protease-sensitive site near Arg277; cleavage by trypsin, chymotrypsin, or proteinase K produces fragments of 33 and 38 kDa and loss of activity. The ovine PGHS-1 crystal structure shows Arg277 located in an exposed loop structure; homology modeling predicts similar loop structures for both human isoforms (hPGHS-1 and -2). We have used limited proteolytic digestion of recombinant hPGHS-1 and hPGHS-2 to probe their structures. Incubation of hPGHS-1 with either trypsin or proteinase K produced 33- and 38-kDa fragments and loss of activity. In contrast, incubation of hPGHS-2 with the same proteases led to cleavage of only a 2- to 3-kDa fragment, with no decrease in activity. Immunoblotting with site-specific antibodies demonstrated that the cleaved fragment originated from the hPGHS-2 C-terminus. Similar immunoblotting experiments indicated that trypsin did not attack the ovine PGHS-1 C-terminus. Mutagenesis was used to replace Pro263 of hPGHS-2 (corresponds to Arg277 of ovine PGHS-1) with arginine, inserting a potential trypsin site. Incubation of this P263R hPGHS-2 mutant with either trypsin or proteinase K resulted in cleavage near the C-terminus and retention of activity, just as with wild-type hPGHS-2. A peptide containing residues 259-268 of the P263R mutant was cleaved by trypsin at the same rate as a peptide corresponding to hPGHS-1 residues 272-281, demonstrating that the sequence differences were not responsible for the lack of tryptic cleavage at residue 263 in the hPGHS-2 mutant. Preincubation of hPGHS-2 with graded levels of guanidinium HCl before incubation with proteinase K did not produce large proteolytic fragments, indicating that the hPGHS-2 loop region was not selectively unfolding. The results point to two regions of significant structural difference between PGHS-1 and -2: the Arg277 loop, which is protease-sensitive in PGHS-1 but protease-resistant in PGHS-2, and the C-terminus, which is protease-sensitive in PGHS-2 but not in PGHS-1.
前列腺素H合酶(PGHS)催化多种生物活性脂质介质生物合成中的关键步骤。两种已知的同工型(PGHS-1和-2)具有约60%的氨基酸同一性,但与底物、激活剂和抑制剂表现出不同的相互作用。先前已证明绵羊PGHS-1在精氨酸277附近有一个独特的蛋白酶敏感位点;胰蛋白酶、胰凝乳蛋白酶或蛋白酶K的切割产生33 kDa和38 kDa的片段并丧失活性。绵羊PGHS-1晶体结构显示精氨酸277位于一个暴露的环结构中;同源性建模预测两种人类同工型(hPGHS-1和-2)具有相似的环结构。我们利用重组hPGHS-1和hPGHS-2的有限蛋白水解消化来探测它们的结构。hPGHS-1与胰蛋白酶或蛋白酶K孵育产生33 kDa和38 kDa的片段并丧失活性。相比之下,hPGHS-2与相同的蛋白酶孵育仅导致一个2至3 kDa片段的切割,活性没有降低。用位点特异性抗体进行免疫印迹表明切割片段起源于hPGHS-2的C末端。类似的免疫印迹实验表明胰蛋白酶不攻击绵羊PGHS-1的C末端。利用诱变将hPGHS-2的脯氨酸263(对应于绵羊PGHS-1的精氨酸277)替换为精氨酸,插入一个潜在的胰蛋白酶位点。该P263R hPGHS-2突变体与胰蛋白酶或蛋白酶K孵育导致C末端附近的切割并保留活性,就像野生型hPGHS-2一样。一个包含P263R突变体259 - 268位残基的肽被胰蛋白酶切割的速率与对应于hPGHS-1 272 - 281位残基的肽相同,表明序列差异不是hPGHS-2突变体中263位残基缺乏胰蛋白酶切割的原因。在与蛋白酶K孵育之前,用分级水平的盐酸胍对hPGHS-2进行预孵育不会产生大的蛋白水解片段,表明hPGHS-2环区域没有选择性展开。结果表明PGHS-1和-2之间存在两个显著的结构差异区域:精氨酸277环,其在PGHS-1中对蛋白酶敏感但在PGHS-2中对蛋白酶抗性;以及C末端,其在PGHS-2中对蛋白酶敏感但在PGHS-1中不敏感。